Found: 10
Select item for more details and to access through your institution.
Web‐based requisitioning, tracking and laboratory result reporting system for clinical trials using a central laboratory: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038627
- By:
- Publication type:
- Article
P3‐232: VALIDATION STUDIES OF NEUROFILAMENT LIGHT AND Aβ‐40 AND Aβ‐42 ASSAYS IN HUMAN PLASMA USING THE SIMOA PLATFORM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1022, doi. 10.1016/j.jalz.2019.06.3262
- By:
- Publication type:
- Article
P1‐265: STANDARDIZATION OF AMYLOID BETA 42 IN‐HOUSE CALIBRATORS FOR A REFERENCE LC‐MS‐MS METHOD FOR ANALYSIS OF AMYLOID BETA 42 IN HUMAN CSF, USING THREE AVAILABLE CERTIFIED REFERENCE MATERIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P341, doi. 10.1016/j.jalz.2019.06.820
- By:
- Publication type:
- Article
P2‐091: ASSAY PERFORMANCE MONITORING FOR AD BIOMARKERS USING POOLED CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P702, doi. 10.1016/j.jalz.2018.06.776
- By:
- Publication type:
- Article
P1‐255: ANALYTICAL AND CLINICAL PERFORMANCE OF AMYLOID BETA PEPTIDES: MEASUREMENT IN CSF OF ADNI2 AND GO PARTICIPANTS BY A LC‐MS‐MS REFERENCE METHOD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P378, doi. 10.1016/j.jalz.2018.06.261
- By:
- Publication type:
- Article
DERIVING A CUT-OFF FOR THE ELECSYS® β-AMYLOID (1–42) IMMUNOASSAY FOR USE IN CLINICAL TRIALS SUPPORTED BY ELI LILLY FOR PATIENTS WITH CLINICALLY DEFINED ALZHEIMER’S DISEASE (AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1317, doi. 10.1016/j.jalz.2017.06.2022
- By:
- Publication type:
- Article
Prospective quality-control monitoring in the context of a clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P386, doi. 10.1016/j.jalz.2015.06.317
- By:
- Publication type:
- Article
The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 772, doi. 10.1016/j.jalz.2015.05.003
- By:
- Publication type:
- Article
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 4, p. 250, doi. 10.1016/j.jalz.2012.01.001
- By:
- Publication type:
- Article
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC--MS/MS Reference Method.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 4, p. 587, doi. 10.1093/clinchem/hvaa012
- By:
- Publication type:
- Article